Human immunodeficiency virus-negative plasmablastic lymphoma: A comprehensive analysis of 114 cases

Liu,Min; Liu,Bailong; Liu,Bin; Wang,Qiang; Ding,Lijuan; Xia,Chengcheng; Dong,Lihua

doi:10.3892/or.2015.3808

Human immunodeficiency virus-negative plasmablastic lymphoma: A comprehensive analysis of 114 cases

Authors:
- Min Liu
- Bailong Liu
- Bin Liu
- Qiang Wang
- Lijuan Ding
- Chengcheng Xia
- Lihua Dong
View Affiliations

Affiliations: Department of Radiation Oncology, The First Hospital, Jilin University, Changchun, Jilin 130021, P.R. China, Department of Hand Surgery, The First Hospital, Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: February 17, 2015 https://doi.org/10.3892/or.2015.3808
Pages: 1615-1620
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human immunodeficiency virus-negative plasmablastic lymphoma (PBL) is an extremely rare entity. Its clinicopathological features, optimal treatment strategy and prognostic factors remain obsure. An extensive search was performed in the English language literature within the Pubmed database using the key words: ‘plasmablastic lymphoma and human immunodeficiency virus-negative or immunocompetent’. Data from 114 patients from 52 articles were analyzed. The mean patient age at diagnosis was 58.90 years (range, 2-86). HIV-negative PBL showed a predilection for elderly individuals (patients older than 60 years, 56.14%) and affected more males than females (M:F, 2.29:1). Ann Arbor stage IV patients accounted for 39.22% while bone marrow involvement was less frequent (12.79%). The Ki-67 index was high with a mean expression of 83%. Epstein-Barr virus (EBV) infection was common being positive in 58.70% of the patients while herpesvirus-8 (HHV-8) infection was rare being positive in only 7.55% of the patients. Immunosuppression was noted in 28.16% of patients. The median overall survival (OS) was 19 months. The 1- and 2-year survival rates were 52.3 and 45.3%, respectively. Age, gender and primary site showed no strong relationship with OS while Immunosuppression, Ann Arbor stage IV and EBV negativity were able to predict a poorer OS. Either complete remission (CR) or partial remission (PR) was superior to the refractory group in OS (P<0.0001 and P=0.0066, respectively). For stage Ⅰ patients, the application of radiotherapy did not improve the OS. In conclusion, HIV-negative PBL is a distinct entity likely occurring in elderly and immunosuppressed individuals. Immunosuppression status, Ann Arbor stage IV, EBV negativity and refractory to treatment are poor prognostic factors of OS in HIV-negative PBL.

View Figures

View References

1	Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al: Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 89:1413–1420. 1997.PubMed/NCBI
2	Castillo JJ, Winer ES, Stachurski D, et al: Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 51:2047–2053. 2010. View Article : Google Scholar : PubMed/NCBI
3	Hatanaka K, Nakamura N, Kishimoto K, Sugino K and Uekusa T: Plasmablastic lymphoma of the cecum: report of a case with cytologic findings. Diagn Cytopathol. 39:297–300. 2011. View Article : Google Scholar
4	Tille JC, Pelte MF, Schwartz J, Dietrich PY and McKee TA: Plasmablastic lymphoma clinically presenting in the urinary tract. Ann Diagn Pathol. 16:219–223. 2012. View Article : Google Scholar
5	Takeuchi M, Ogawa F, Onishi T and Moriyama Y: Plasmablastic lymphoma in an elderly immunocompetent patient. Pathol Int. 62:347–350. 2012. View Article : Google Scholar : PubMed/NCBI
6	Mihaljevic BS, Todorovic MR, Andjelic BM, Antic DA and Perunicic Jovanovic MD: Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient. Med Oncol. 29:1186–1189. 2012. View Article : Google Scholar
7	Zhang LY, Lin HY, Gao LX, et al: Primary central nervous system plasmablastic lymphoma presenting in human immunodeficiency virus-negative but Epstein-Barr virus-positive patient: a case report. Diagn Pathol. 7:512012. View Article : Google Scholar : PubMed/NCBI
8	Lipstein M, O’Connor O, Montanari F, Paoluzzi L, Bongero D and Bhagat G: Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma. Clin Lymphoma Myeloma Leuk. 10:E43–E46. 2010. View Article : Google Scholar
9	Khurana A and Jalpota Y: Plasmablastic lymphoma in a human immunodeficiency virus negative patient. Indian J Pathol Microbiol. 53:368–369. 2010. View Article : Google Scholar : PubMed/NCBI
10	Heiser D, Müller H, Kempf W, Eisendle K and Zelger B: Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient. J Am Acad Dermatol. 67:e202–e205. 2012. View Article : Google Scholar : PubMed/NCBI
11	Wang HW, Yang W, Sun JZ, Lu JY, Li M and Sun L: Plasmablastic lymphoma of the small intestine: Case report and literature review. World J Gastroenterol. 18:6677–6681. 2012. View Article : Google Scholar : PubMed/NCBI
12	Tani J, Miyoshi H, Nomura T, et al: A case of plasmablastic lymphoma of the liver without human immunodeficiency virus infection. World J Gastroenterol. 19:6299–6303. 2013. View Article : Google Scholar : PubMed/NCBI
13	Brahmania M, Sylwesterowic T and Leitch H: Plasmablastic lymphoma in the ano-rectal junction presenting in an immunocompetent man: a case report. J Med Case Rep. 5:1682011. View Article : Google Scholar : PubMed/NCBI
14	Nguyen DD, Loo BW Jr, Tillman G, et al: Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 82:521–525. 2003. View Article : Google Scholar : PubMed/NCBI
15	Lin F, Zhang K, Quiery AT Jr, Prichard J and Schuerch C: Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient a case report and review of the literature. Arch Pathol Lab Med. 128:581–584. 2004.PubMed/NCBI
16	Tzankov A, Brunhuber T, Gschwendtner A and Brunner A: Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion. Histopathology. 46:348–350. 2005. View Article : Google Scholar : PubMed/NCBI
17	Scheper MA, Nikitakis NG, Fernandes R, Gocke CD, Ord RA and Sauk JJ: Oral plasmablastic lymphoma in an HIV-negative patient: A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 100:198–206. 2005. View Article : Google Scholar : PubMed/NCBI
18	Masgala A, Christopoulos C, Giannakou N, Boukis H, Papadaki T and Anevlavis E: Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman. Ann Hematol. 86:615–618. 2007. View Article : Google Scholar : PubMed/NCBI
19	Hashimoto M, Inaguma S, Kasai K, et al: Plasmablastic lymphoma of the stomach in an HIV-negative patient. Pathol Int. 62:763–770. 2012. View Article : Google Scholar : PubMed/NCBI
20	Guan B, Zhang X, Hu W, et al: Plasmablastic lymphoma of the oral cavity in an HIV-negative patient. Ann Diagn Pathol. 15:436–440. 2011. View Article : Google Scholar
21	Mansoor M, Alani FS, Aslam MB, Kumar SN, Sahasrabudhe N and Khan D: A case report of cecal plasmablastic lymphoma in a HIV-negative patient. Eur J Gastroenterol Hepatol. 24:332–335. 2012. View Article : Google Scholar : PubMed/NCBI
22	Matsuki E, Miyakawa Y, Asakawa S, et al: Identification of loss of p16 expression and upregulation of MDR-1 as genetic events resulting from two novel chromosomal translocations found in a plasmablastic lymphoma of the uterus. Clin Cancer Res. 17:2101–2109. 2011. View Article : Google Scholar : PubMed/NCBI
23	Saraceni C, Agostino N, Cornfield DB and Gupta R: Plasmablastic lymphoma of the maxillary sinus in an HIV-negative patient: a case report and literature review. Springerplus. 2:1422013. View Article : Google Scholar : PubMed/NCBI
24	Marques I, Lagos A and Costa-Neves B: Gastric plasmablastic lymphoma in HIV-negative patient. Rev Esp Enferm Dig. 105:166–167. 2013. View Article : Google Scholar : PubMed/NCBI
25	Choi SY, Cho YA, Hong SD, Lee JI, Hong SP and Yoon HJ: Plasmablastic lymphoma of the oral cavity in a human immunodeficiency virus-negative patient: a case report with literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 117:e115–e120. 2014. View Article : Google Scholar
26	Liu JJ, Zhang L, Ayala E, et al: Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review. Leuk Res. 35:1571–1577. 2011. View Article : Google Scholar : PubMed/NCBI
27	Kim JE, Kim YA, Kim WY, et al: Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma. 50:582–587. 2009. View Article : Google Scholar : PubMed/NCBI
28	Qing X, Sun N, Chang E, French S, Ji P and Yue C: Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma. Exp Mol Pathol. 90:85–90. 2011. View Article : Google Scholar
29	Suzuki Y, Yoshida T, Nakamura N, et al: CD3- and CD4-positive plasmablastic lymphoma: a literature review of Japanese plasmablastic lymphoma cases. Intern Med. 49:1801–1805. 2010. View Article : Google Scholar : PubMed/NCBI
30	Tiong IS, Strauss M, Lau MB and Chiruka S: Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review. Case Rep Hematol. 2013:5417832013.PubMed/NCBI
31	Gogia A and Bakhshi S: Plasmablastic lymphoma of oral cavity in a HIV-negative child. Pediatr Blood Cancer. 55:390–391. 2010. View Article : Google Scholar : PubMed/NCBI
32	McGlaughlin KL, Bajel A and Mow CD: A case of plasmablastic lymphoma harbouring an IgH/MYC translocation in a HIV negative individual. Pathology. 42:697–699. 2010. View Article : Google Scholar : PubMed/NCBI
33	Cha JM, Lee JI, Joo KR, et al: A case report with plasmablastic lymphoma of the jejunum. J Korean Med Sci. 25:496–500. 2010. View Article : Google Scholar : PubMed/NCBI
34	Teruya-Feldstein J, Chiao E, Filippa DA, et al: CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol. 15:1673–1679. 2004. View Article : Google Scholar : PubMed/NCBI
35	Colomo L, Loong F, Rives S, et al: Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 28:736–747. 2004. View Article : Google Scholar : PubMed/NCBI
36	Borenstein J, Pezzella F and Gatter KC: Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology. 51:774–777. 2007. View Article : Google Scholar : PubMed/NCBI
37	Takahashi Y, Saiga I, Fukushima J, et al: Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient. Pathol Int. 59:868–873. 2009. View Article : Google Scholar : PubMed/NCBI
38	Liu F, Asano N, Tatematsu A, et al: Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder. Histopathology. 61:1183–1197. 2012. View Article : Google Scholar : PubMed/NCBI
39	Redmond M, Quinn J, Murphy P, Patchett S and Leader M: Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn’s disease after immunosuppressive therapy. J Clin Pathol. 60:80–81. 2007. View Article : Google Scholar : PubMed/NCBI
40	Verma S, Nuovo GJ, Porcu P, Baiocchi RA, Crowson AN and Magro CM: Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol. 32:35–39. 2005. View Article : Google Scholar : PubMed/NCBI
41	Rao DD, Aggarwal N, Anehosur V, Doddihal H, Shiraganvi M and Gopalkrishnan K: Plasmablastic lymphoma of the oral cavity in immunocompetent patients: report of two cases. Int J Oral Maxillofac Surg. 39:1036–1039. 2010. View Article : Google Scholar : PubMed/NCBI
42	Nicol I, Boye T, Carsuzaa F, et al: Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol. 149:889–891. 2003. View Article : Google Scholar : PubMed/NCBI
43	Ustun C, Reid-Nicholson M, Nayak-Kapoor A, et al: Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol. 88:351–358. 2009. View Article : Google Scholar
44	Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A and Buffa R: Plasmablastic lymphoma of the stomach. A case report. Haematologica. 83:87–89. 1998.PubMed/NCBI
45	Kravetz JD, Rose MG, Payne-Blackman S and Federman DG: Plasmablastic lymphoma presenting as an arm mass in an individual negative for human immunodeficiency virus: a case report. Clin Lymphoma Myeloma. 6:493–495. 2006. View Article : Google Scholar : PubMed/NCBI
46	Dasanu CA, Bauer F, Codreanu I, Padmanabhan P and Rampurwala M: Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib. Hematol Oncol. 31:164–166. 2013. View Article : Google Scholar
47	Miller DV, Mookadam F, Mookadam M, Edwards WD and Macon WR: Primary cardiac plasmablastic (diffuse large B-cell) lymphoma mimicking left ventricular aneurysm with mural thrombus. Cardiovasc Pathol. 16:111–114. 2007. View Article : Google Scholar : PubMed/NCBI
48	Mondal SK, Bera H, Biswas PK and Mallick MG: High-grade plasmablastic neoplasm of humerus in an HIV-negative patient, which was indeterminate between plasmablastic lymphoma and plasmablastic myeloma. J Cancer Res Ther. 7:214–216. 2011. View Article : Google Scholar : PubMed/NCBI
49	Black CL, Foster-Smith E, Lewis ID, Faull RJ and Sidhu SK: Post-transplant plasmablastic lymphoma of the skin. Australas J Dermatol. 54:277–282. 2013. View Article : Google Scholar
50	Ojanguren J, Collazos J, Martínez C, Alvarez J and Mayo J: Epstein-Barr virus-related plasmablastic lymphomas arising from long-standing sacrococcygeal cysts in immunosuppressed patients. AIDS. 17:1582–1584. 2003. View Article : Google Scholar : PubMed/NCBI
51	Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, et al: Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica. 95:1342–1349. 2010. View Article : Google Scholar : PubMed/NCBI
52	Saba NS, Dang D, Saba J, et al: Bortezomib in plasmablastic lymphoma: a case report and review of the literature. Onkologie. 36:287–291. 2013. View Article : Google Scholar : PubMed/NCBI
53	Robak T, Urbańska-Ryś H, Strzelecka B, et al: Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter’s syndrome. Eur J Haematol. 67:322–327. 2001. View Article : Google Scholar
54	Castillo JJ, Winer ES, Stachurski D, et al: HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk. 11:185–189. 2011. View Article : Google Scholar : PubMed/NCBI
55	Castillo JJ and Reagan JL: Plasmablastic lymphoma: a systematic review. Sci World J. 11:687–696. 2011. View Article : Google Scholar